CT - 278
Overall and Progression-Free Survival in Patients With Epstein-Barr Virus-Driven Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Following Tabelecleucel Treatment: Results From the Phase 3 ALLELE Trial
Christina Hughes
Poster Presenter: Christina Hughes
